Tumor size predicts survival within stage IA non-small cell lung cancer.
about
Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary resultsEGFR mutations as a prognostic and predictive marker in non-small-cell lung cancerAnalysis of cancer mutation signatures in blood by a novel ultra-sensitive assay: monitoring of therapy or recurrence in non-metastatic breast cancerInhibition of vinyl carbamate-induced pulmonary adenocarcinoma by indole-3-carbinol and myo-inositol in A/J miceNomograms for predicting recurrence and survival of invasive pathological stage IA non-small cell lung cancer treated by video assisted thoracoscopic surgery lobectomy.The assessment of the role of baseline low-dose CT scan in patients at high risk of lung cancerSub-100nm gold nanomatryoshkas improve photo-thermal therapy efficacy in large and highly aggressive triple negative breast tumorsInvasive size is an independent predictor of survival in pulmonary adenocarcinoma.Validation of a molecular and pathological model for five-year mortality risk in patients with early stage lung adenocarcinoma.Sublobar resection for early-stage lung cancer.Relationship between tumor size and survival in non-small-cell lung cancer (NSCLC): an analysis of the surveillance, epidemiology, and end results (SEER) registryIncreased Expression of TGFβR2 Is Associated with the Clinical Outcome of Non-Small Cell Lung Cancer Patients Treated with Chemotherapy.Predictive value of 18F-FDG PET and CT morphologic features for recurrence in pathological stage IA non-small cell lung cancer.Integrating regional and community lung cancer services to improve patient care.Accuracy of CT parameters for assessment of tumour size and aggressiveness in lung adenocarcinoma with bronchoalveolar elements.Cancer as a moving target: understanding the composition and rebound growth kinetics of recurrent tumors.Effect of dietary green tea extract and aerosolized difluoromethylornithine during lung tumor progression in A/J strain micePort-access thoracoscopic anatomical lung subsegmentectomy.FDG PET/CT and mediastinal nodal metastasis detection in stage T1 non-small cell lung cancer: prognostic implications.Comparison of the 7(th) and proposed 8(th) editions of the AJCC/UICC TNM staging system for non-small cell lung cancer undergoing radical surgery.Sublobar Resection for Clinical Stage IA Non-small-cell Lung Cancer in the United StatesCell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma.Lobectomy and limited resection in small-sized peripheral non-small cell lung cancer.Treatment options for stage I non-small-cell lung carcinoma patients not suitable for lobectomy.Early detection and screening of lung cancer.Sublobar resection versus lobectomy for stage I non-small cell lung cancer: an appropriate choice in elderly patients?Elucidation of relationship between tumor size and survival in non-small-cell lung cancer patients can aid early decision making in clinical drug development.Nonintubated thoracoscopic lobectomy plus lymph node dissection following segmentectomy for central type pulmonary masses.Designing exploratory cancer trials using change in tumour size as primary endpoint.Computed tomography morphologic features of pulmonary adenocarcinoma with brain/bone metastasis.Segmental 18F-FDG-PET/CT in a single pulmonary nodule: a better cost/effectiveness strategy.
P2860
Q24630546-60393245-EE2F-4D98-A898-2D4B2B9DCDDFQ26852507-D4EFCAB7-F69F-4B6D-84D6-77BA3B5FA440Q33507538-34260542-900C-432C-BA81-11AF7101FCC2Q33615285-E79DD1FE-EEE2-47C3-9AFB-2449C1B77E28Q33639243-1BD4153F-389E-4974-8901-3FE5F70E93D6Q33933709-80FD5341-2563-48D3-A3CE-831C1DD994CBQ34145579-FFE7877A-F4F3-41C8-AAE4-10F9B1AA1E5FQ34330363-CEC386B3-2B3C-4353-B002-BBA8045C771CQ34743874-B690DB5C-AB13-49BF-8CD0-01412DAE9B48Q35200550-7710B334-6E0C-4276-9225-FB3FBA701EBEQ35202454-BC28D248-B88C-4A1C-8FBD-A5BE12A288ADQ35739691-91BDFB0E-4BCD-4836-8BAF-72DF1EC1E2CCQ36151953-42B1DB61-065F-4D66-A15F-F3E6BE77BF76Q36256396-C3FAD2C2-8442-4F1F-A4AB-9EB11B8F6466Q36324943-9FB02299-E8E7-4A99-9FD2-CF72D35CF234Q36595762-893D7992-51C2-4837-A00D-1228078B5EFCQ36837995-3CD7C5F0-4953-4870-A6A7-98802B1B130AQ36842493-AFF5C425-B6AF-415D-B4D2-5A6E6669C84BQ37063199-CAB54FDF-0EAA-44B4-92D1-48A9341F2CA0Q37264472-EBA2360F-05D2-424F-B366-0B9A63FD597FQ37293737-FA2E94DC-C6B8-4197-85CD-EAE7E2BAD940Q37376521-C7ACA2B7-AA4E-472B-B4E5-7D4BCF5164F2Q37528303-3C6D0CA6-93A3-4428-B98D-A7C63D63E2A1Q37614582-292BDAA2-3260-4717-B8CC-8744C34D3CCDQ37789035-EA3306A1-39DF-48BD-BF44-2EE7382A6723Q39845494-4AD80982-01B8-4F17-81BB-10F1905F9916Q39979882-B4CE20F0-2837-4BF8-97C9-6F4D4684F079Q41822133-5FBCFA8E-314B-41EE-96FB-8805372CBC43Q43459402-5EECFE0E-A324-4F26-870E-FA86D840F201Q48311323-9A702F9E-33EE-4E08-9065-2EA64E7493D2Q49017504-9F13D64A-C890-423A-AFBC-81E53619B650
P2860
Tumor size predicts survival within stage IA non-small cell lung cancer.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Tumor size predicts survival within stage IA non-small cell lung cancer.
@en
Tumor size predicts survival within stage IA non-small cell lung cancer.
@nl
type
label
Tumor size predicts survival within stage IA non-small cell lung cancer.
@en
Tumor size predicts survival within stage IA non-small cell lung cancer.
@nl
prefLabel
Tumor size predicts survival within stage IA non-small cell lung cancer.
@en
Tumor size predicts survival within stage IA non-small cell lung cancer.
@nl
P2093
P356
P1433
P1476
Tumor size predicts survival within stage IA non-small cell lung cancer.
@en
P2093
Daniel Libby
Jeffrey L Port
Mark Pasmantier
Michael S Kent
Nasser K Altorki
Robert J Korst
P304
P356
10.1378/CHEST.124.5.1828
P407
P577
2003-11-01T00:00:00Z